• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Theravance Bio Ord (NQ: TBPH )

    8.250 +0.070 (+0.86%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 238,216
    Open 8.300
    Bid (Size) 8.070 (4)
    Ask (Size) 8.440 (2)
    Prev. Close 8.180
    Today's Range 8.230 - 8.370
    52wk Range 7.440 - 11.71
    Shares Outstanding 48,922,083
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Cracking The Code: Understanding Analyst Reviews For Theravance Biopharma
    Via Benzinga
    TBPH Stock Earnings: Theravance Biopharma Beats EPS, Misses Revenue for Q2 2024
    TBPH stock results show that Theravance Biopharma beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -28.82%
    -28.82%
    1 Month
    -16.41%
    -16.41%
    3 Month
    -16.24%
    -16.24%
    6 Month
    -2.48%
    -2.48%
    1 Year
    -18.64%
    -18.64%

    More News

    Read More
    Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Sidoti Events, LLC's Virtual June Small-Cap Conference
    Via ACCESSWIRE
    TBPH Stock Earnings: Theravance Biopharma Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Recap: Theravance Biopharma Q4 Earnings
    Via Benzinga
    A Preview Of Theravance Biopharma's Earnings
    Via Benzinga
    Theravance Biopharma Earnings Preview
    Via Benzinga
    BTIG Research Predicts Over 118% Rally for These 3 Stocks
    Via InvestorPlace
    Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics
    Via InvestorPlace
    Earnings Scheduled For February 26, 2024
    Via Benzinga
    Logitech Posts Q3 Results, Joins Coinbase And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Why Is Lung Disease Focused Theravance Biopharma Stock Trading Lower Today?
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    7 Short-Squeeze Stocks That Are Screaming for Speculation
    Via InvestorPlace
    Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal
    Via Talk Markets
    Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Stocks That Hit 52-Week Lows On Friday
    Via Benzinga
    Earnings Scheduled For November 7, 2023
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    Via Benzinga
    Takeda Moves Out From Licensing Agreement With Theravance Biopharma
    Via Benzinga
    Earnings Scheduled For May 8, 2023
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.